Indication

Histiocytic neoplasm

A histiocytic neoplasm is a rare clonal hematologic malignancy characterized by the abnormal proliferation and infiltration of mature cells belonging to the mononuclear phagocyte system, including monocytes, macrophages, and dendritic cells. Read more about Histiocytic neoplasm

1 drugs 1 manufacturers

Advertisement

Drugs that treat it

Common Histiocytic neoplasm therapies.

Showing 1–1 of 1 drugs

Filter & compare in the drug finder →Opens the drug finder with Histiocytic neoplasm preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Histiocytic neoplasm.

A histiocytic neoplasm is a rare clonal hematologic malignancy characterized by the abnormal proliferation and infiltration of mature cells belonging to the mononuclear phagocyte system, including monocytes, macrophages, and dendritic cells.

These neoplasms can present at any age, affecting pediatric and adult populations alike, and may arise as solitary lesions or as widespread multiorgan disease involving the bones, skin, central nervous system, lungs, liver, spleen, and lymph nodes.

The clinical spectrum ranges from indolent, localized conditions such as juvenile xanthogranuloma to aggressive, systemic diseases including Erdheim-Chester disease, Rosai-Dorfman disease, Langerhans cell histiocytosis, and histiocytic sarcoma.

Pathophysiologically, these disorders are frequently driven by mutually exclusive somatic activating mutations within the MAPK signaling pathway, most notably *BRAF* and *MAP2K1* mutations, leading to constitutive cellular proliferation and tissue inflammation.

Personalize your experience

Follow Histiocytic neoplasm and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it